Balgopal Commercial secures listing approval for 23.38 lakh shares
Balgopal Commercial Ltd received BSE approval for listing 23,38,000 equity shares issued to promoters at a premium of ₹50 each. The shares were issued via preferential allotment following warrant conversion. Trading approval is pending submission of depository confirmations and compliance with SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Balgopal Commercial Ltd has secured listing approval from BSE Limited for 23,38,000 equity shares issued to its promoter group on a preferential basis. The shares, issued at a premium of ₹50 each, were allotted pursuant to the conversion of warrants. This approval is crucial for the company as it allows these shares to be traded on the exchange, subject to final procedural clearances.
The approval was granted via letter number LOD/PREF/AP/FIP/451/2026-27 dated June 29, 2026. The shares bear distinctive numbers ranging from 20910001 to 23248000. The issuance was conducted in accordance with Regulation 28(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Conditions for Trading
While the listing has been approved, trading in these shares will commence only after the company fulfills specific regulatory requirements. Balgopal Commercial must submit confirmation letters from NSDL and CDSL regarding the crediting of shares to beneficiary accounts and the lock-in of pre-preferential holdings, if applicable. Additionally, the company must provide listing approval from the National Stock Exchange of India Ltd., if applicable.
Regulatory Compliance
The company is required to ensure compliance with Regulation 167 of the SEBI (ICDR) Regulations. Furthermore, if the shareholding pattern changes by more than 2% of the total paid-up share capital, the company must file the updated pattern in XBRL mode under Regulation 31(1)(c) of SEBI LODR Regulations, 2015.
BSE has mandated that the company apply for trading approval within seven working days from the date of the listing approval, as per Schedule XIX of ICDR Regulations and a SEBI circular dated June 21, 2023. Failure to comply with this timeline may result in penalties.
Details of the Allotment
| Parameter | Details |
|---|---|
| Total Shares Approved | 23,38,000 |
| Face Value | ₹10 each |
| Issue Price | ₹10 + ₹50 premium |
| Allottee | Promoter / Promoter Group |
| Basis | Preferential Allotment / Warrant Conversion |
Historical Stock Returns for Balgopal Commercial
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.91% | +3.93% | +19.35% | +6.32% | +27.45% | +5,965.57% |
What impact will the conversion of these warrants into equity have on Balgopal Commercial's promoter holding percentage?
How does the company intend to utilize the capital raised from the ₹50 premium per share?
Will the company seek similar preferential allotments in the future to fund expansion or reduce debt?































